Abstract

MRI-guided radiotherapy systems have the potential to bring two important concepts in modern radiotherapy together: adaptive radiotherapy and biological targeting. Based on frequent anatomical and functional imaging, monitoring the changes that occur in volume, shape as well as biological characteristics, a treatment plan can be updated regularly to accommodate the observed treatment response. For this purpose, quantitative imaging biomarkers need to be identified that show changes early during treatment and predict treatment outcome. This review provides an overview of the current evidence on quantitative MRI measurements during radiotherapy and their potential as an imaging biomarker on MRI-guided radiotherapy systems.

Highlights

  • At the turn of the century, two novel concepts were introduced in radiation oncology that acknowledged the complexity of tumor biology and that presented the challenges that must be met to improve the outcome of radiotherapy

  • Based on frequent imaging, monitoring the changes that occur in volume, shape as well as biological characteristics, a treatment plan can be updated regularly to Frontiers in Oncology | www.frontiersin.org van Houdt et al Quantitative MRI for biological image-guided adaptive radiotherapy (BIGART)

  • We summarize the current evidence on repeated Quantitative MRI (qMRI) measurements during radiotherapy and the potential for such an approach with MRI-guided radiotherapy (MRIgRT) systems

Read more

Summary

Frontiers in Oncology

Heide UA (2021) Quantitative Magnetic Resonance Imaging for Biological Image-Guided Adaptive. MRI-guided radiotherapy systems have the potential to bring two important concepts in modern radiotherapy together: adaptive radiotherapy and biological targeting. Based on frequent anatomical and functional imaging, monitoring the changes that occur in volume, shape as well as biological characteristics, a treatment plan can be updated regularly to accommodate the observed treatment response. For this purpose, quantitative imaging biomarkers need to be identified that show changes early during treatment and predict treatment outcome. This review provides an overview of the current evidence on quantitative MRI measurements during radiotherapy and their potential as an imaging biomarker on MRI-guided radiotherapy systems

INTRODUCTION
QUANTITATIVE MANETIC RESONANCE IMAGING BIOMARKERS
Tissue cell density
No time points
Brain metastases
TECHNICAL VALIDATION
Findings
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.